Cardiometabolic Effects of Denosumab in Premenopausal Women with Breast Cancer Receiving Estradiol Suppression: RCT

CONCLUSIONS: In premenopausal women receiving estradiol suppression, denosumab decreases some measures of fat mass with no detectable effects on other measures of body composition or metabolic parameters.PMID:38181438 | DOI:10.1210/clinem/dgae003

Source: The Journal of Clinical Endocrinology and Metabolism - January 5, 2024 Category: Endocrinology Authors: Sabashini K Ramchand Rudolf Hoermann Shane White Belinda Yeo Prudence A Francis Cecilia L H Xu Jeffrey D Zajac Ego Seeman Mathis Grossmann Source Type: research